122 / 136
120 /
Atul Ltd
|
Annual Report 2009-10
5 Details of associates considered in consolidation:
(Rs crores)
Name of associate Country of
incorporation
Main activities Ownership
interest
and voting
power
Original
cost of
investments
Amount of
goodwill
/ capital
reserve
included
in original
cost
Accumulated
Loss at the
year end
March 31,
2009
Carrying
amount of
investments
at the year
end (see
Note (1)
below)
1
2
3
4
5
6
7
8
(a) Amal Ltd
India
Dye
Intermediates
36.75%
5.15
-
55.61
0.24
(b) Gujarat
Synthwood Ltd
India
PVC sheets and
Panels
34.64%
1.30
-
17.08
0.07
(c) AtRo Ltd
India
Agrochemicals
50.00%
0.50
-
0.43
0.50
(d) Atul Bioscience
Ltd
India
Pharmaceuticals
28.00%
-
3.85
6.95
-
76.97
0.81
Note: (i) After provision for diminution in value of investments in case of 'a' and 'b'.
(ii) Value of investment in Atul Bioscience Ltd under column '5' and '8' is Rs 140
6 Deferred Tax adjustments recognised in the financial statements:
(Rs crores)
Particulars
Balance
As at
March 31, 2010
Charge | credit
Balance
As at
March 31, 2009
During the year
Deferred tax liabilities:
On account of timing difference in
(a) Depreciation | impairment loss
29.05
(1.94)
30.99
29.05
(1.94)
30.99
Deferred tax assets:
On account of timing difference in
(a) Provision for leave encashment
4.36
0.22
4.14
(b) 43 B expenses allowable
0.42
(0.19)
0.61
(c) Provision for doubtful debts
-
(2.28)
2.28
(d) Provision for doubtful advances
0.06
(3.39)
3.45
(e) Payment under VRS
1.63
(1.16)
2.79
6.47
(6.80)
13.27
22.58
4.86
17.72
(f) Deferred tax assets of subsidiaries
(0.01)
(0.01)
(0.01)
Net deferred tax liability | (assets)
22.57
4.85
17.71
Schedule
forming part of the Consolidated accounts
SCHEDULE 16 NOTES FORMING PART OF THE CONSOLIDATED ACCOUNTS
(contd)
121